SecSonar.com

Claritev Corporation (CTEV)

Claritev Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Claritev Corporation (CTEV) is a Medical - Healthcare Information Services company based in US with a market capitalization of $428.8M. Revenue grew 3.7% year-over-year and free cash flow was negative at -$12.3M. This page tracks CTEV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2.7K employees · IPO Apr 3, 2020

Valuation

Valuation & price

$13.87 · as of May 17, 2026 · -80.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$72.45$43.01$13.57Jul 25Dec 25Jul 26Jul 7, 25$48.33Jul 9, 25$49.94Jul 11, 25$46.32Jul 15, 25$43.63Jul 17, 25$44.58Jul 21, 25$42.89Jul 23, 25$43.74Jul 25, 25$39.68Jul 29, 25$38.65Jul 31, 25$39.87Aug 4, 25$39.31Aug 6, 25$51.14Aug 11, 25$61.61Aug 13, 25$70.38Aug 15, 25$71.61Aug 19, 25$67.70Aug 21, 25$68.66Aug 25, 25$71.61Aug 27, 25$71.85Aug 29, 25$68.91Sep 3, 25$68.38Sep 5, 25$69.82Sep 9, 25$72.45Sep 11, 25$61.64Sep 16, 25$57.07Sep 18, 25$55.39Sep 22, 25$51.50Sep 24, 25$52.66Sep 26, 25$51.45Sep 30, 25$53.08Oct 2, 25$46.41Oct 6, 25$51.00Oct 8, 25$57.36Oct 10, 25$53.73Oct 14, 25$55.26Oct 16, 25$56.53Oct 21, 25$66.00Oct 23, 25$66.42Oct 27, 25$71.36Oct 29, 25$68.60Oct 31, 25$65.10Nov 4, 25$62.87Nov 6, 25$61.96Nov 10, 25$57.84Nov 12, 25$58.62Nov 14, 25$43.26Nov 18, 25$42.29Nov 20, 25$45.23Nov 25, 25$52.21Nov 28, 25$54.07Dec 2, 25$45.05Dec 4, 25$36.95Dec 8, 25$32.98Dec 10, 25$35.00Dec 12, 25$37.45Dec 16, 25$38.35Dec 18, 25$41.11Dec 22, 25$42.84Dec 24, 25$42.69Dec 29, 25$42.41Jan 2, 26$33.89Jan 6, 26$31.71Jan 8, 26$31.21Jan 12, 26$31.96Jan 14, 26$30.47Jan 16, 26$30.44Jan 21, 26$28.85Jan 23, 26$28.86Jan 27, 26$27.04Jan 29, 26$26.93Feb 2, 26$27.78Feb 4, 26$25.20Feb 9, 26$23.79Feb 11, 26$20.80Feb 13, 26$22.99Feb 18, 26$23.56Feb 20, 26$23.27Feb 24, 26$13.57Feb 26, 26$14.17Mar 2, 26$14.43Mar 4, 26$17.82Mar 6, 26$17.21Mar 10, 26$16.33Mar 12, 26$16.02Mar 17, 26$16.92Mar 19, 26$15.34Mar 23, 26$15.45Mar 25, 26$15.53Mar 27, 26$15.54Mar 31, 26$16.34Apr 2, 26$17.46Apr 7, 26$16.92Apr 9, 26$17.88Apr 13, 26$17.37Apr 15, 26$19.01Apr 17, 26$20.59Apr 22, 26$21.91Apr 24, 26$23.81Apr 28, 26$23.49Apr 30, 26$24.33May 4, 26$25.31May 6, 26$26.47May 8, 26$27.00May 12, 26$28.53May 14, 26$23.47May 18, 26$16.42May 20, 26$21.24May 22, 26$21.67May 28, 26$24.56Jun 1, 26$26.99Jun 3, 26$26.27Jun 5, 26$25.84Jun 9, 26$28.35Jun 11, 26$32.03Jun 15, 26$30.61Jun 17, 26$29.75Jun 22, 26$28.44Jun 24, 26$30.49Jun 26, 26$33.15Jul 2, 26$32.64
$13.4752-week range$72.58
Loading valuation history…

Fundamentals

Key fundamentals

$428.8M

Market cap

3.7%

Revenue growth (YoY)

27.6%

Gross margin

-$12.3M

Free cash flow (USD)

$4.6B

Net debt

1.8%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$1.0BFY 2019$982.9MFY 2020$937.8MFY 2021$1.1BFY 2022$1.1BFY 2023$961.5MFY 2024$930.6MFY 2025$965.4M
$1B$965.4M

Free cash flow by year

2018 → 2025

FY 2018$228.7MFY 2019$217.9MFY 2020$306.6MFY 2021$320.1MFY 2022$282.6MFY 2023$62.9MFY 2024$-10.5MFY 2025$-12.3M
$228.7M-$12.3M

Gross margin by year

2021 → 2025

FY 202184.3%FY 202281.1%FY 202375.5%FY 202474.3%FY 202527.6%
84.3%27.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

4

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventInvestigation ClosureJun 22, 2026Filing
  • Insider buyInsider Buy $25KCarol Nutter · SVP, Chief People Officer · $24.9KJun 10, 2026Filing
  • Insider buyInsider Buy $259KDalton Travis · Director, Pres., CEO & Executive Chair · $258.6KMay 19, 2026Filing
  • Insider buyInsider Buy $160KPrince John Michael · Director · $160KMay 19, 2026Filing
  • Insider buyInsider Buy $50KKim Michael · EVP, Chief Digital Officer · $49.9KMay 19, 2026Filing
  • 8-K eventDOJ Investigation UpdateMay 18, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventStockholder Meeting ResultsApr 30, 2026Filing

Questions

Frequently asked questions

What is Claritev Corporation's market cap?

Claritev Corporation (CTEV) has a market capitalization of $428.8M.

What is CTEV's P/E ratio?

A meaningful P/E ratio is not available for CTEV — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying CTEV stock?

Yes — SEC Form 4 filings show 4 open-market insider buys and 0 sells at Claritev Corporation in the last 90 days.

Same arena

Related companies in Medical - Healthcare Information Services

EVH

Evolent Health, Inc.

$443.7M

NRC

National Research Corporation

$449.9M

TBRG

TruBridge, Inc.

$389.2M

SOPH

SOPHiA GENETICS S.A.

$360M

SLP

Simulations Plus, Inc.

$349.2M

SY

So-Young International Inc.

$263.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.